Clinical Trials Browser

INDUSTRY × Non-small Cell Lung Cancer Metastatic × Erlotinib Hydrochloride × Clear all

NCT00701558 2016-06-24

A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Unresectable Advanced and/or Metastatic Non-Small Cell Lung Cancer

Phase 2 Completed

20 enrolled 8 charts

Non-small Cell Lung Cancer Metastatic